AdlerMW. Enhanced depressant effect of tetrabenazine after repeated administration. Psychopharmacologia, 5:393–396. 1964.
2.
AhmedI, DagincourtPG, MillerLG, ShaderRI. Possible interaction between fluoxetine and pimozide causing sinus bradycardia. Can J Psychiatry, 38:62–63. 1993.
3.
BaptistaT, ElFakihY, UzcateguiE, SandiaI, TalamoE, Araujo de BaptistaE, BeaulieuS. Pharmacological management of atypical antipsychotic-induced weight gain. CNS Drugs, 22:477–495. 2008.
4.
CacciaS. Metabolism of the newer antidepressants. An overview of the pharmacological and pharmacokinetic implications. Clin Pharmacokinet, 34:281–302. 1998.
5.
CorrellCU. Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents. J Clin Psychiatry, 69:26–36. 2008.
6.
FlockhartDA, DriciMD, KerbuschT, SoukhovaN, RichardE, PearlePL, MahalSK, BabbVJ. Studies on the mechanism of a fatal clarithromycin-pimozide interaction in a patient with Tourette syndrome. J Clin Psychopharmacol, 20:317–324. 2000.
7.
FriedmanEH. Re: Bradycardia and somnolence after adding fluoxetine to pimozide regimen. Can J Psychiatry, 39:634. 1994.
8.
GabbayV, CoffeyB. Novel treatments in Tourette's Disorder: Omega 3 fatty acids. Boston, American Academy of Child and Adolescent Psychiatry Annual Meeting, 2007.
9.
GabbayV, CoffeyB, AlonsoC, GuttmanL, GottliebL, HirschG. A Double-Blind Placebo-Controlled Study of Omega-3 Fatty Acids in Children and Adolescents with Tourette's Disorder. Phoenix, Arizona, New Clinical Drug Evaluation Unit (NCDEU) Meeting, 2008.
10.
HimleMB, WoodsDW, PiacentiniJC. Brief review of habit reversal training for Tourette syndrome. J Child Neurol, 21:719–725. 2006.
11.
LarsonPS. Deep brain stimulation for psychiatric disorders. Neurotherapeutics, 5:50–58. 2008.
12.
PhillipsKA. Placebo-controlled study of pimozide augmentation of fluoxetine in body dysmorphic disorder. Am J Psychiatry, 162:377–379. 2005.
13.
SalleeFR, PollockBG, StillerRL, StullS, EverettG, PerelJM. Pharmacokinetics of pimozide in adults and children with Tourette's syndrome. J Clin Pharmacol, 27:776–781. 1987.
14.
ShinL, BregmanH, FrazierJ, NovesN. An overview of obesity in children with psychiatric disorders taking atypical antipsychotics. Harv Rev Psychiatry, 16:69–79. 2008.
15.
SwainJE, ScahillL, LombrosoPJ, KingRA, LeckmanJF. Tourette syndrome and tic disorders: A decade of progress. J Am Acad Child Adolesc Psychiatry, 46:947–968. 2007.